KIORA PHARMACEUTICALS, INC. Proceeds from Issuance of Private Placement
KIORA PHARMACEUTICALS, INC. (KPRX) reported Proceeds from Issuance of Private Placement of $5.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2026-08-07
- KIORA PHARMACEUTICALS, INC. proceeds from issuance of private placement for the quarter ending 2025-12-31 was $0.00.
- KIORA PHARMACEUTICALS, INC. proceeds from issuance of private placement for the quarter ending 2025-09-30 was $0.00.
- KIORA PHARMACEUTICALS, INC. proceeds from issuance of private placement for the quarter ending 2025-06-30 was $0.00.
- KIORA PHARMACEUTICALS, INC. proceeds from issuance of private placement for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- KIORA PHARMACEUTICALS, INC. proceeds from issuance of private placement for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- KIORA PHARMACEUTICALS, INC. proceeds from issuance of private placement for fiscal 2024 was $15.00M, a 7399.43% increase from fiscal 2023.
- KIORA PHARMACEUTICALS, INC. proceeds from issuance of private placement for fiscal 2023 was $200.00K.
- KIORA PHARMACEUTICALS, INC. proceeds from issuance of private placement for fiscal 2022 was $0.00.
| Period end | Proceeds from Issuance of Private Placement | Proceeds from Issuance of Private Placement as first filed | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 3 month as first filed | Proceeds from Issuance of Private Placement 6 month | Proceeds from Issuance of Private Placement 9 month | Proceeds from Issuance of Private Placement 12 month | Proceeds from Issuance of Private Placement 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $5.00M 10-Q · filed 2026-08-07 | |||||||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $0.00 derived: sum of 2 quarters · filed 2026-03-25 | $0.00 derived: sum of 3 quarters · filed 2026-08-07 | $0.00 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $0.00 derived: sum of 2 quarters · filed 2026-08-07 | $0.00 10-Q · filed 2025-11-07 | $0.00 derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $0.00 10-Q · filed 2026-08-07 | $0.00 derived: sum of 3 quarters · filed 2026-08-07 | $0.00 derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-09 | $0.00 derived: sum of 2 quarters · filed 2026-03-25 | $0.00 derived: sum of 3 quarters · filed 2026-03-25 | -$1.14K derived: sum of 4 quarters · filed 2026-03-25 | ||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $0.00 derived: sum of 2 quarters · filed 2026-03-25 | -$1.14K derived: sum of 3 quarters · filed 2026-03-25 | $15.00M 10-K · filed 2026-03-25 | ||||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$1.14K derived: sum of 2 quarters · filed 2025-11-07 | $15.00M 10-Q · filed 2025-11-07 | $15.00M derived: sum of 4 quarters · filed 2025-11-07 | ||||
| 2024-06-30 | -$1.14K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $15.00M 10-Q · filed 2025-08-08 | $15.00M derived: sum of 3 quarters · filed 2025-08-08 | $15.00M derived: sum of 4 quarters · filed 2025-08-08 | ||||
| 2024-03-31 | $15.00M 10-Q · filed 2025-05-09 | $15.00M derived: sum of 2 quarters · filed 2025-05-09 | $15.00M derived: sum of 3 quarters · filed 2025-05-09 | $15.00M derived: sum of 4 quarters · filed 2025-05-09 | ||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | $0.00 derived: sum of 2 quarters · filed 2025-03-25 | $0.00 derived: sum of 3 quarters · filed 2025-03-25 | $200.00K 10-K · filed 2025-03-25 | $115.72K 10-K · filed 2024-03-25 | |||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $0.00 derived: sum of 2 quarters · filed 2024-11-08 | $200.00K 10-Q · filed 2024-11-08 | $200.00K derived: sum of 4 quarters · filed 2024-11-08 | ||||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $200.00K 10-Q · filed 2024-08-09 | $200.00K derived: sum of 3 quarters · filed 2024-08-09 | $200.00K derived: sum of 4 quarters · filed 2024-08-09 | ||||
| 2023-03-31 | $200.00K 10-Q · filed 2024-05-10 | $115.72K 10-Q · filed 2023-05-09 | $200.00K derived: sum of 2 quarters · filed 2024-05-10 | $200.00K derived: sum of 3 quarters · filed 2024-05-10 | $200.00K derived: sum of 4 quarters · filed 2024-05-10 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $0.00 derived: sum of 2 quarters · filed 2024-03-25 | $0.00 derived: sum of 3 quarters · filed 2024-03-25 | $0.00 10-K · filed 2024-03-25 | ||||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | |||||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $0.00 10-Q · filed 2023-08-08 | ||||||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-09 | |||||||
| 2021-01-06 | $8.00M 10-K · filed 2023-03-23 | |||||||
| 2020-12-31 | $1.80M 10-K · filed 2021-03-25 | |||||||
| 2020-01-03 | $5.00 10-K · filed 2021-03-25 | $5.00M 10-Q · filed 2020-05-06 | ||||||
| 2019-12-31 | $1.90M 10-K · filed 2020-03-04 | |||||||
| 2019-10-02 | $1.80M 10-K · filed 2021-03-25 | $1.90M 10-Q · filed 2020-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |